Rhodes DR - Search Results

1

Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.

Hovelson DH, McDaniel AS, Cani AK, Johnson B, Rhodes K, Williams PD, Bandla S, Bien G, Choppa P, Hyland F, Gottimukkala R, Liu G, Manivannan M, Schageman J, Ballesteros-Villagrana E, Grasso CS, Quist MJ, Yadati V, Amin A, Siddiqui J, Betz BL, Knudsen KE, Cooney KA, Feng FY, Roh MH, Nelson PS, Liu CJ, Beer DG, Wyngaard P, Chinnaiyan AM, Sadis S, Rhodes DR, Tomlins SA. Hovelson DH, et al. Among authors: rhodes dr, rhodes k. Neoplasia. 2015 Apr;17(4):385-99. doi: 10.1016/j.neo.2015.03.004. Neoplasia. 2015. PMID: 25925381 Free PMC article.

2

Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Rhodes DR, et al. Cancer Res. 2002 Aug 1;62(15):4427-33. Cancer Res. 2002. PMID: 12154050

3

DNA microarrays: implications for clinical medicine.

Rhodes DR, Chinnaiyan AM. Rhodes DR, et al. J Invest Surg. 2002 Sep-Oct;15(5):275-9. doi: 10.1080/08941930290086074. J Invest Surg. 2002. PMID: 12396431 Review.

4

Dysregulation of the annexin family protein family is associated with prostate cancer progression.

Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. Xin W, et al. Among authors: rhodes dr. Am J Pathol. 2003 Jan;162(1):255-61. doi: 10.1016/S0002-9440(10)63816-3. Am J Pathol. 2003. PMID: 12507908 Free PMC article.

5

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA. Rhodes DR, et al. J Natl Cancer Inst. 2003 May 7;95(9):661-8. doi: 10.1093/jnci/95.9.661. J Natl Cancer Inst. 2003. PMID: 12734317

6

Prostate cancer biomarkers: a current perspective.

Kumar-Sinha C, Rhodes DR, Yu J, Chinnaiyan AM. Kumar-Sinha C, et al. Among authors: rhodes dr. Expert Rev Mol Diagn. 2003 Jul;3(4):459-70. doi: 10.1586/14737159.3.4.459. Expert Rev Mol Diagn. 2003. PMID: 12877385 Review.

7

Statistical issues and methods for meta-analysis of microarray data: a case study in prostate cancer.

Ghosh D, Barette TR, Rhodes D, Chinnaiyan AM. Ghosh D, et al. Funct Integr Genomics. 2003 Dec;3(4):180-8. doi: 10.1007/s10142-003-0087-5. Epub 2003 Jul 22. Funct Integr Genomics. 2003. PMID: 12884057 Free article.

8

ONCOMINE: a cancer microarray database and integrated data-mining platform.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Rhodes DR, et al. Neoplasia. 2004 Jan-Feb;6(1):1-6. doi: 10.1016/s1476-5586(04)80047-2. Neoplasia. 2004. PMID: 15068665 Free PMC article.

9

Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.

Sreekumar A, Laxman B, Rhodes DR, Bhagavathula S, Harwood J, Giacherio D, Ghosh D, Sanda MG, Rubin MA, Chinnaiyan AM. Sreekumar A, et al. Among authors: rhodes dr. J Natl Cancer Inst. 2004 Jun 2;96(11):834-43. doi: 10.1093/jnci/djh145. J Natl Cancer Inst. 2004. PMID: 15173267

10

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Rhodes DR, et al. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9309-14. doi: 10.1073/pnas.0401994101. Epub 2004 Jun 7. Proc Natl Acad Sci U S A. 2004. PMID: 15184677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page